Activity Profile In Vitro of Micafungin against Spanish Clinical Isolates of Common and Emerging Species of Yeasts and Molds

被引：40

作者：

Cuenca-Estrella, Manuel ^{[1
]}

Gomez-Lopez, Alicia ^{[1
]}

Mellado, Emilia ^{[1
]}

Monzon, Araceli ^{[1
]}

Buitrago, Maria J. ^{[1
]}

Rodriguez-Tudela, Juan L. ^{[1
]}

机构：

[1] Inst Salud Carlos III, Dept Mycol, Spanish Natl Ctr Microbiol, Madrid 28220, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2009年 / 53卷 / 05期

关键词：

ANTIFUNGAL SUSCEPTIBILITY; GLOBAL SURVEILLANCE; EUROPEAN COMMITTEE; FILAMENTOUS FUNGI; CANDIDA-ALBICANS; CASPOFUNGIN; ANIDULAFUNGIN; ASPERGILLUS; VORICONAZOLE; AGENTS;

D O I：

10.1128/AAC.01543-08

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A collection of 2,278 isolates belonging to 86 different fungal species was tested with micafungin and eight other drugs using the EUCAST procedures. Micafungin was active against species of Candida and Aspergillus (even azole-resistant species) as well as Penicillium spp., Scedosporium apiospermum, and Acremonium spp. It was inactive for species of Basidiomycota and Mucorales and for multiresistant species such as those of Fusarium.

引用

页码：2192 / 2195

页数：4

共 22 条

[1] Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia [J].

Antachopoulos, Charalampos ;

Meletiadis, Joseph ;

Sein, Tin ;

Roilides, Emmanuel ;

Walsh, Thomas J. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) :321-328

[2] Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp. [J].

Arikan, S ;

Yurdakul, P ;

Hascelik, G .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (08) :2640-2643

[3] Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi [J].

Cuenca-Estrella, M ;

Gomez-Lopez, A ;

Mellado, E ;

Buitrago, MJ ;

Monzon, A ;

Rodriguez-Tudela, JL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) :917-921

[4] Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006 [J].

Dannaoui, E. ;

Lortholary, O. ;

Raoux, D. ;

Bougnoux, M. E. ;

Galeazzi, G. ;

Lawrence, C. ;

Moissenet, D. ;

Poilane, I. ;

Hoinard, D. ;

Dromer, F. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) :778-781

[5] Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples:: Analysis by site of isolation [J].

Guinea, J ;

Peláez, T ;

Alcalá, L ;

Ruiz-Serrano, MJ ;

Bouza, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3495-3497

[6] Susceptibility patterns of Candida species recovered from Canadian intensive care units [J].

Laverdiere, Michel ;

Labbe, Annie-Claude ;

Restieri, Christiane ;

Rotstein, Coleman ;

Heyland, Daren ;

Madger, Sheldon ;

Stewart, Thomas .

JOURNAL OF CRITICAL CARE, 2007, 22 (03) :245-250

[7] Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species [J].

Odds, FC ;

Motyl, M ;

Andrade, R ;

Bille, J ;

Cantón, E ;

Cuenca-Estrella, M ;

Davidson, A ;

Durussel, C ;

Ellis, D ;

Foraker, E ;

Fothergill, AW ;

Ghannoum, MA ;

Giacobbe, RA ;

Gobernado, M ;

Handke, R ;

Laverdière, M ;

Lee-Yang, W ;

Merz, WG ;

Ostrosky-Zeichner, L ;

Pemán, J ;

Perea, S ;

Perfect, JR ;

Pfaller, MA ;

Proia, L ;

Rex, JH ;

Rinaldi, MG ;

Rodriguez-Tudela, JL ;

Schell, WA ;

Shields, C ;

Sutton, DA ;

Verweij, PE ;

Warnock, DW .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (08) :3475-3482

[8] Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States [J].

Ostrosky-Zeichner, L ;

Rex, JH ;

Pappas, PG ;

Hamill, RJ ;

Larsen, RA ;

Horowitz, HW ;

Powderly, WG ;

Hyslop, N ;

Kauffman, CA ;

Cleary, J ;

Mangino, JE ;

Lee, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3149-3154

[9] Filamentous fungi in a tertiary care hospital: Environmental surveillance and susceptibility to antifungal drugs [J].

Panagopoulou, Paraskevi ;

Filioti, Joanna ;

Farmaki, Evangelia ;

Maloukou, Avgi ;

Roilides, Emmanuel .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (01) :60-67

[10] Resistance to echinocandin-class antifungal drugs [J].

Perlin, David S. .

DRUG RESISTANCE UPDATES, 2007, 10 (03) :121-130

← 1 2 3 →